Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial
Rousel, Jannik, Bergmans, Menthe E., van der Meulen, Laura W.J., Pagan, Lisa, de Bruin, Digna T., de Kam, Marieke L., Klarenbeek, Naomi B., Bouwstra, Joke A., Seyger, Marieke M.B., van den Reek, Juul M.P.A., Niemeyer-van der Kolk, Tessa, Rissmann, Robert, van Doorn, Martijn B.A.
Published in Journal of the American Academy of Dermatology (01.02.2024)
Published in Journal of the American Academy of Dermatology (01.02.2024)
Get full text
Journal Article
53711 Guselkumab induction therapy is effective, safe and long lasting in mild psoriasis patients, results from a randomized, placebo-controlled exploratory trial
Rissmann, Robert, Rousel, Jannik, Bergmans, Menthe, van der Meulen, Laura, de Kam, Marieke, Bouwstra, Joke, Seyger, Marieke, van den Reek, Juul, Klarenbeek, Naomi, Niemeyer-van der Kolk, Tessa, van Doorn, Martijn
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article